Physician profile
Peter J Lindner
NPI 1285673970
$893.28
in general payments reported to CMS, 2019-2025
20 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $52.26 · 2021: $13.87 · 2022: $121 · 2023: $195 · 2024: $201 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $250.11 | 2022-2025 | Farxiga, Airsupra |
| Amgen INC. | $143.32 | 2019-2025 | Repatha, Otezla, Repatha |
| Abbott Laboratories | $84.13 | 2022-2023 | Mitraclip, Freestyle Libre 2 |
| Lilly USA, LLC | $76.70 | 2019-2025 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $41.60 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $33.71 | 2025 | |
| Glaxosmithkline, LLC. | $28.20 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.61 | 2022 | |
| Astellas Pharma US INC | $23.16 | 2025 | Veozah |
| Medtronic Vascular, INC. | $22.50 | 2020 | |
| Boston Scientific Corporation | $21.99 | 2024 | Watchman Flx |
| Merck Sharp & Dohme LLC | $21.18 | 2025 | Capvaxive, Gardasil 9 |
| Abbvie INC. | $21.06 | 2019 | |
| Exact Sciences Corporation | $20.19 | 2025 | The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $15.67 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.13 | 2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $12.78 | 2022 | |
| Scilex Pharmaceuticals INC. | $12.28 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.01 | 2019 | |
| Allergan, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lindner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.